股票 › BCAX
Bicara 制药 BCAX
美股市值排名 #3592
$8.65 +$0.46 (+5.62%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $8.65 0.00%
开盘$8.32
昨收$8.19
当日区间$8.06 – $8.93
成交量1.01M
市值$572.40M
市盈率（TTM）–
股息率–
BCAX 相关新闻
匹配 Bicara Therapeutics 或代码 BCAX 的头条新闻，按最新排序。
- JonesTrading Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $30
- Stifel Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Cuts Target Price to $45 负面
- Mizuho Securities Reaffirms Their Hold Rating on Bicara Therapeutics Inc. (BCAX)
- Wedbush Reaffirms Their Buy Rating on Bicara Therapeutics Inc. (BCAX)
- Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX) 正面
- Morgan Stanley Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $37
- Analysts Conflicted on These NA Names: Bicara Therapeutics Inc. (BCAX), CoreWeave (CRWV) and Cardinal Infrastructure Group, Inc. (CDNL)
- BofA Securities Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $34
- BTIG Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Raises Target Price to $39 正面
- Analysts Offer Insights on NA Companies: Enhanced Group (ENHA), MNTN, Inc Class A (MNTN) and Bicara Therapeutics Inc. (BCAX)
- Analysts Have Conflicting Sentiments on These NA Companies: Bending Spoons (BSP), EToro (ETOR) and Bicara Therapeutics Inc. (BCAX)
- Analysts Offer Insights on NA Companies: Smithfield Foods (SFD), Bicara Therapeutics Inc. (BCAX) and Concentra Group Holdings Parent, Inc. (CON)
- BTIG Maintains Bicara Therapeutics(BCAX.US) With Buy Rating, Maintains Target Price $28
- Bicara Therapeutics Inc. (BCAX) Gets a Hold From Wells Fargo
- BofA Securities Maintains Bicara Therapeutics(BCAX.US) With Buy Rating
暂无评论——快来第一个聊聊 BCAX。